"Dana-Farber Cancer Researchers Under Investigation for Data Manipulation"

Dana-Farber Cancer Institute is facing allegations of data manipulation in research papers authored by four of its top scientists, including CEO Laurie Glimcher and COO William Hahn. An investigation has been ongoing for over a year, with potential retractions and corrections being considered for several papers. The institute's research integrity officer confirmed that the allegations are credible and warrant further examination, while emphasizing that the presence of image discrepancies does not necessarily indicate misconduct. The institute is committed to a thorough review of the original data and taking appropriate corrective actions.